Point72 Europe (London) LLP Bausch & Lomb Corp Transaction History
Point72 Europe (London) LLP
- $1.06 Billion
- Q1 2024
A detailed history of Point72 Europe (London) LLP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 506,909 shares of BLCO stock, worth $7.46 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
506,909Holding current value
$7.46 Million% of portfolio
0.83%Shares
1 transactions
Others Institutions Holding BLCO
# of Institutions
92Shares Held
37.6MCall Options Held
15.4KPut Options Held
127K-
Fil LTD Hamilton, D08.19MShares$120 Million0.15% of portfolio
-
Goldentree Asset Management LP New York, NY4.72MShares$69.4 Million6.58% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.75MShares$55.1 Million3.59% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$51.5 Million0.54% of portfolio
-
River Road Asset Management, LLC1.89MShares$27.8 Million0.45% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.15B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...